- GlobeNewswire•12 days ago
PROSTVAC® overall survival data anticipated in the second half of 2017 COPENHAGEN, Denmark, January 4, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today provided guidance for the current estimated ...
- GlobeNewswire•14 days ago
COPENHAGEN, Denmark, January 3, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that the Company upgrades its expectations for the 2016 year-end cash preparedness from approximately ...
- GlobeNewswire•18 days ago
Study is exploring potential benefits of combining a cancer vaccine and PD-1 checkpoint inhibitor COPENHAGEN, Denmark, December 29, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced the ...
BAVA.CO : Summary for Bavarian Nordic A/S - Yahoo Finance
Bavarian Nordic A/S (BAVA.CO)
Copenhagen - Copenhagen Delayed Price. Currency in DKK
Add to watchlist
|Day's Range||290.00 - 301.50|
|52 Week Range||197.00 - 306.00|
|PE Ratio (TTM)||-40.90|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|